Bill Ackman

Bill Ackman

Last Update: 04-22-2016

Number of Stocks: 8
Number of New Stocks: 0

Total Value: $12,460 Mil
Q/Q Turnover: 0%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Bill Ackman' s Profile & Performance

Profile

William Ackman, co-investment manager for hedge-fund group Gotham Partners LP, formed Pershing Square in November 2003 with $54 million raised from three investors. Ackman got his start in the real estate business, where he worked for his father prior to starting Gotham.

Investing Philosophy

Bill Ackman is an activist investor. He buys the common stocks of public companies, and pushes for changes so that the market can realize the values of the companies. Ackman buys stocks trading at a discount, and sells when the companies reach their appraised value.

Total Holding History

Performance of Pershing Square, L.P.

YearReturn (%)S&P500 (%)Excess Gain (%)
201436.913.6923.2
20139.732.39-22.7
201213.316-2.7
3-Year Cumulative70.2 (19.4%/year)74.6 (20.4%/year)-4.4 (-1%/year)
2011-1.12.11-3.2
201029.715.0614.6
5-Year Cumulative118.3 (16.9%/year)105.1 (15.5%/year)13.2 (1.4%/year)
200940.626.4614.1
2008-13-3724.0
2007225.4916.5
200622.515.796.7
200539.94.9135.0
10-Year Cumulative458.2 (18.8%/year)109.4 (7.7%/year)348.8 (11.1%/year)
200442.610.8831.7

Top Ranked Articles

Ackman to Testify About Valeant Before Senate Valeant names Joseph Papa of Perrigo as new CEO
Activist investor Bill Ackman (Trades, Portfolio) will testify before the Senate Special Committee on Aging Wednesday regarding his involvement with Valeant Pharmaceuticals (NYSE:VRX), along with outgoing CEO Michael Pearson, just a day after Joseph Papa of Perrigo (NYSE:PRGO) was announced as Pearson’s replacement. Read more...
Why Bill Ackman Is Cutting Back on Canadian Pacific Exploring Ackman's motivation to reduce stake in railroad company
Bill Ackman (Trades, Portfolio) has been cutting back on Canadian Pacific (NYSE:CP) by selling a massive amount of shares as shown by GuruFocus' Real Time Picks. The move is somewhat surprising because on the recent quarterly call, the firm’s outlook was very bullish: Read more...
Canadian Pacific Ends Plans to Acquire Norfolk Southern Canadian Pacific investors can continue to expect gains
This week Canadian Pacific (NYSE:CP) announced it would no longer be continuing its acquisition bid for Norfolk Southern (NYSE:NSC). After repeated refutes from Norfolk Southern, Canadian Pacific was preparing to bring the acquisition proposal to Norfolk Southern’s shareholders. Read more...
Notes From the Pershing Square 1st Quarter Call Summary of Ackman and Pershing's analysts comments on portfolio companies
Bill Ackman (Trades, Portfolio) of Pershing Square Capital just held his first quarter call discussing the fund’s holdings. Read more...
Highlights of Bill Ackman’s 1st Quarter Pershing Square Conference Call Main points on stocks like Valeant and Herbalife that contributed to 26% dive and how they still have value
Head of hedge fund Pershing Square Management Bill Ackman (Trades, Portfolio) hosted his first-quarter conference call Wednesday where he provided details about his many losses and few gains in the past several quarters. He also outlined developments at his top investments and where he sees value versus the market. Read more...
» More Bill Ackman Articles

Commentaries and Stories

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Ackman to Testify About Valeant Before Senate Valeant names Joseph Papa of Perrigo as new CEO Bill Ackman - Ackman To Testify About Valeant Before Senate
Activist investor Bill Ackman (Trades, Portfolio) will testify before the Senate Special Committee on Aging Wednesday regarding his involvement with Valeant Pharmaceuticals (NYSE:VRX), along with outgoing CEO Michael Pearson, just a day after Joseph Papa of Perrigo (NYSE:PRGO) was announced as Pearson’s replacement. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Why Bill Ackman Is Cutting Back on Canadian Pacific Exploring Ackman's motivation to reduce stake in railroad company Bill Ackman - Why Bill Ackman Is Cutting Back On Canadian Pacific
Bill Ackman (Trades, Portfolio) has been cutting back on Canadian Pacific (NYSE:CP) by selling a massive amount of shares as shown by GuruFocus' Real Time Picks. The move is somewhat surprising because on the recent quarterly call, the firm’s outlook was very bullish: More...

LONG, GURU, ACKMAN, RAILROADS,


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

With Ackman Down It May Be Right Time to Back Him Pershing Square trades at a 10% discount, won't charge performance fees for awhile and manager has enviable track record Bill Ackman - With Ackman Down It May Be Right Time To Back Him
Pershing Square Holdings trades at a 10% discount to its NAV ($15.73 to $17.43). Historically, the discount has averaged around 5% since the IPO. The holding IPO’ed in 2014. More...

LONG, GURU, VALEANT,


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Canadian Pacific Ends Plans to Acquire Norfolk Southern Canadian Pacific investors can continue to expect gains Bill Ackman - Canadian Pacific Ends Plans To Acquire Norfolk Southern
This week Canadian Pacific (NYSE:CP) announced it would no longer be continuing its acquisition bid for Norfolk Southern (NYSE:NSC). After repeated refutes from Norfolk Southern, Canadian Pacific was preparing to bring the acquisition proposal to Norfolk Southern’s shareholders. More...

INDUSTRIALS


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Notes From the Pershing Square 1st Quarter Call Summary of Ackman and Pershing's analysts comments on portfolio companies Bill Ackman - Notes From The Pershing Square 1st Quarter Call
Bill Ackman (Trades, Portfolio) of Pershing Square Capital just held his first quarter call discussing the fund’s holdings. More...

LONG, ACKMAN, ACTIVIST


  • Currently 5.00/5

Rating: 5.0/5 (2 votes)

Highlights of Bill Ackman’s 1st Quarter Pershing Square Conference Call Main points on stocks like Valeant and Herbalife that contributed to 26% dive and how they still have value Bill Ackman - Highlights Of Bill Ackman’s 1st Quarter Pershing Square Conference Call
Head of hedge fund Pershing Square Management Bill Ackman (Trades, Portfolio) hosted his first-quarter conference call Wednesday where he provided details about his many losses and few gains in the past several quarters. He also outlined developments at his top investments and where he sees value versus the market. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

In Search of Profitable Stocks Using Gross Profitability A discussion of what gross profitability is and why you should take notice Bill Ackman - In Search Of Profitable Stocks Using Gross Profitability
This metric is awesome. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Time To Buy Allergan After the Pfizer tax inversion deal fell through, Allergan shares got hammered, and it's time to pick up some shares Bill Ackman,John Paulson,Steve Mandel,Jana Partner - Time To Buy Allergan
Allergan (NYSE:AGN) stock has dropped a lot because of rumors Pfizer (NYSE:PFE) will walk away from their deal. More...

LONG, DRUGS, PHARMA


  • Currently 4.59/5

Rating: 4.6/5 (17 votes)

Avoid Piggybacking The pitfalls of piggybacking fellow investors on investment ideas Warren Buffett,Bill Ackman,Jeff Ubben - Avoid Piggybacking
I don’t know how many articles you’ve read about Valeant (VRX) in the past few weeks, but it’s probably safe to say too many. This article, you might be happy to hear, has very little to do with Valeant – mostly because I have nothing new or intelligent to say about the company (it’s buried deep in my “too hard” pile). Instead, it’s about following the lead of others when investing. More...

NONE


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Bill Ackman Trims Position in Mondelez International Guru reduces stake nearly 50% by slashing more than 20 million shares Bill Ackman - Bill Ackman Trims Position In Mondelez International
Guru Bill Ackman (Trades, Portfolio) reduced his position in Mondelez International Inc. (NASDAQ:MDLZ) by more than 47% with the sale of 20,424,117 shares on March 16. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

The Bromance at the Heart of the Valeant Disaster A detailed look at Bill Ackman's Valeant disaster Bill Ackman, Warren Buffett - The Bromance At The Heart Of The Valeant Disaster
When, in April 2014, Bill Ackman (Trades, Portfolio) and Michael Pearson came on stage together at the Equitable Center in midtown Manhattan to unveil their unorthodox bid to buy drug company Allergan (NYSE:AGN), the two men couldn’t have appeared more different. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Bill Ackman Explains Expanded Role at Valeant in New Letter Pershing Square to influence CEO selection, capital allocation and strategy Bill Ackman - Bill Ackman Explains Expanded Role At Valeant In New Letter
LETTER TO SHAREHOLDERS More...

  • Currently 4.64/5

Rating: 4.6/5 (11 votes)

What Is Downside? A discussion of downside analysis and factors affecting the objectivity of downside analysis Mohnish Pabrai,Bill Ackman,Warren Buffett - What Is Downside?
One of the most quoted sayings in investing goes like this: “If you take care of the downside, the upside will take care of itself.” More...

  • Currently 4.83/5

Rating: 4.8/5 (6 votes)

An Attempt to Value Valeant Just for Fun When, and if, we have quality accounting numbers, here is how I see Valeant's value Bill Ackman - An Attempt To Value Valeant Just For Fun
Until last week, I had been just a casual observer of Valeant (NYSE:VRX). My knowledge of the company was limited to: More...

  • Currently 4.33/5

Rating: 4.3/5 (3 votes)

Valeant: Heads I Win, Tails I Don't Lose Much Though it has many obstacles, Valeant is too cheap to ignore Bill Ackman, Lou Simpson - Valeant: Heads I Win, Tails I Don't Lose Much
There are several reasons to dislike Valeant Pharmaceuticals (NYSE:VRX). Lack of management credibility, accounting irregularities and other legal investigations related to a price increase on a couple of drugs have caused its share price to fall from the high of $260 to $28.95. Investors in the company, including me, had a stomach-churning experience. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Ackman Named to Valeant Board as Search for New CEO Begins Valeant has asked CFO Howard Schiller to resign Bill Ackman, Ruane Cunniff - Ackman Named To Valeant Board As Search For New CEO Begins
Valeant Pharmaceuticals (NYSE:VRX) announced today that it will replace CEO Michael Pearson and name major shareholder Bill Ackman (Trades, Portfolio) to the board of directors. Pearson will continue to serve as CEO until a successor is named, and Katharine Stevenson will resign from the board to make room for Ackman. More...

  • Currently 2.75/5

Rating: 2.8/5 (4 votes)

What We Can Learn Vicariously From Valeant Fiasco Learning vicariously, as Charlie Munger says, is one of the best ways to learn Charlie Munger, Bill Ackman - What We Can Learn Vicariously From Valeant Fiasco
One of the most-read news of this week has been the Valeant (NYSE:VRX) statement on Tuesday, with a lower guidance for first quarter 2016, coupled with red ink across the fourth quarter results. To add scrutiny, the news have been followed with more interest as Bill Ackman, who was cherished by Wall Street last year as one of the most promising hedge fund managers, has 20% of its hedge fund capital invested in Valeant. So without saying who is wrong and who is right in this story, what are the lessons that we can learn vicariously, as Charlie Munger (Trades, Portfolio) suggests us to do? More...

  • Currently 1.83/5

Rating: 1.8/5 (6 votes)

Bill Ackman Could Learn From Technical Analysis Guru's investing style is the 'pennies in front of a stream roller' trade in a different form Bill Ackman - Bill Ackman Could Learn From Technical Analysis
Taking concentrated fundamental bets is no different than playing craps in Vegas. More...

TRADE MANAGEMENT, RISK MANAGEMENT, CHARTS, RISK


  • Currently 4.00/5

Rating: 4.0/5 (2 votes)

The Art of Finding, Analyzing and Researching Stocks Faster and Better The importance of being decisive Bill Ackman - The Art Of Finding, Analyzing And Researching Stocks Faster And Better
Snap. More...

DECISION MAKING, JUDGMENT CALL


  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Pershing Square Sells Mondelez to Raise Cash After Valeant Plunge Bill Ackman previously sold some Mondelez to buy more Valeant Bill Ackman - Pershing Square Sells Mondelez To Raise Cash After Valeant Plunge
Bill Ackman (Trades, Portfolio), after a string of misfortune including a 50% one-day drop in his holding Valeant Pharmaceuticals (NYSE:VRX), unloaded some of his stake in Mondelez (NASDAQ:MDLZ), he said in a letter to shareholders Wednesday. More...

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK